EHC

Over the past six months (March 2026 - September 2026), Encompass Health's stock has been influenced by several events. The Q2 2026 earnings report showed strong results with net operating revenues up 9.6% and inpatient discharges up 5.6%, leading to a significant stock increase of +12.55% on August 5, 2026, and raised full-year EPS guidance. New hospital openings and expansions in Pennsylvania, South Carolina, and Georgia were viewed positively, expanding capacity. In July 2026, the company increased and declared a dividend on its common stock. Encompass Health also announced and priced private offerings of 5.875% senior notes due 2034 in August 2026 to manage debt and fund growth. Reports of insider selling by executives in late August and early September 2026 are being monitored by investors. The stock experienced a 90-day share price return of 21.87% and a year-to-date gain of 14.46% as of September 21, 2026, though its 1-year total shareholder return slipped by 2.71%; analysts project a potential upside of 21.70%.